Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach - Quiz - MDSpire

Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach

  • By

  • Afif Nakhleh

  • Ahmad Mahamid

  • Yaniv Yechiel

  • Leonard Saiegh

  • Sagit Zolotov

  • Salomon M. Stemmer

  • May 4, 2026

  • 0 min

Share

Original Source(s)

Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach

  • by Afif Nakhleh, Ahmad Mahamid, Yaniv Yechiel, Leonard Saiegh, Sagit Zolotov, Salomon M. Stemmer

  • May 4, 2026

Related Content

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer